Integrated Single‐Cell and Bulk Transcriptomic Analyses Identify Endothelial Cell–Associated Biomarkers and Potential Therapeutic Targets in Atherosclerosis
International Journal of Clinical Practice · 2026-01 · 2026 (1)
DOI: 10.1155/ijcp/8154363 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Clinical Practice, online erschienen am 20.11.2026. Verfasst von Zhe Peng und 9 weiteren Autor:innen. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atherosclerosis (AS) is a major pathological basis of cardiovascular events, including coronary artery disease and ischemic stroke. Although lipid‐lowering, antiplatelet, and anti‐inflammatory therapies have substantially improved clinical outcomes, considerable residual cardiovascular risk persists. A deeper understanding of the molecular mechanisms underlying the initiation and progression of AS, together with the identification of novel disease biomarkers and potential therapeutic targets, therefore, remains clinically important. Endothelial dysfunction is an early and critical event in atherogenesis; however, endothelial cell–associated molecules have not yet been systematically characterized.
Methods
We applied an integrative transcriptomic strategy combining single‐cell transcriptomics, bulk RNA sequencing, and machine learning to identify endothelial cell–associated molecular features in AS. The single‐cell RNA sequencing (scRNA‐seq) dataset GSE255895 from the Gene Expression Omnibus (GEO) database was first analyzed to characterize the cellular composition of atherosclerotic tissues and identify endothelial cell–associated genes. Weighted gene coexpression network analysis (WGCNA) was subsequently performed using GSE100927 to identify gene modules closely associated with AS. Candidate genes were obtained by integrating endothelial cell–associated genes, genes from the key WGCNA module, and differentially expressed genes. Random forest modeling and receiver operating characteristic (ROC) curve analysis were then used to evaluate the discriminatory performance of the candidate genes, followed by molecular docking analysis of high‐priority candidates. Finally, the expression of the core genes was validated by quantitative real‐time PCR (qRT‐PCR) in serum samples from patients with AS and healthy controls. Results scRNA‐seq revealed the cellular composition of atherosclerotic tissues and identified gene expression features associated with endothelial cell function. Functional enrichment analysis showed that endothelial cell–associated genes were predominantly involved in angiogenesis, extracellular matrix remodeling, cell adhesion, and inflammatory regulation. WGCNA identified the blue module as most strongly associated with the atherosclerotic phenotype, with its genes mainly enriched in extracellular matrix organization, PI3K‐AKT signaling, and processes related to vascular remodeling. Integrative analysis yielded 13 endothelial cell–associated candidate genes. Random forest and ROC analyses further identified CTNNAL1, FGL2, GADD45B, GRB14, SOCS2, and TC2N as genes with strong discriminatory performance (AUC ≥ 0.85). Molecular docking predicted stable binding poses between the proteins encoded by these core genes and aspirin or atorvastatin. Validation in clinical serum samples demonstrated concordant expression changes in all six core genes in patients with AS.
Conclusions
By integrating single‐cell and bulk transcriptomic analyses, this study systematically identified key endothelial cell–associated molecules in AS and prioritized candidate genes with potential diagnostic value and therapeutic relevance. These findings provide a framework for understanding endothelial molecular regulation in AS and may support the development of more precise diagnostic and therapeutic strategies.
Zitieren
APA
Peng, Z., Li, Z., Hu, H., Chen, L., Weng, L., Wu, S., Zhu, W., Liu, X., Zhu, J., & Wu, B. (2026). Integrated Single‐Cell and Bulk Transcriptomic Analyses Identify Endothelial Cell–Associated Biomarkers and Potential Therapeutic Targets in Atherosclerosis. International Journal of Clinical Practice, 2026(1). https://doi.org/10.1155/ijcp/8154363
Vancouver
Peng Z, Li Z, Hu H, Chen L, Weng L, Wu S, et al. Integrated Single‐Cell and Bulk Transcriptomic Analyses Identify Endothelial Cell–Associated Biomarkers and Potential Therapeutic Targets in Atherosclerosis. International Journal of Clinical Practice. 2026;2026(1). doi:10.1155/ijcp/8154363
BibTeX
@article{Peng2026,
author = {Peng, Zhe and Li, Ziyu and Hu, Haoran and Chen, Liang and Weng, Lijun and Wu, Shile and Zhu, Wenjun and Liu, Xinghua and Zhu, Jiang and Wu, Biao},
title = {Integrated Single‐Cell and Bulk Transcriptomic Analyses Identify Endothelial Cell–Associated Biomarkers and Potential Therapeutic Targets in Atherosclerosis},
journal = {International Journal of Clinical Practice},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/ijcp/8154363}
}
EUVIMED